Peregrine Asset Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Peregrine Asset Advisers's LLY Position: Q2 2026 in Review
Peregrine Asset Advisers increased its Eli Lilly (LLY) stake by 151% in Q2 2026, buying an estimated $4.43M and bringing the position to 7,214 shares worth $8.65M. The position accounts for 1.88% of the portfolio, ranked #14.
Peregrine Asset Advisers first reported a position in LLY in Q1 2020 and has held it in 16 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Peregrine Asset Advisers held 7,214 shares of Eli Lilly worth $8.65M as of Q2 2026.
- Peregrine Asset Advisers bought 4,339 Eli Lilly shares in Q2 2026, an estimated $4.43M.
- Eli Lilly made up 1.88% of Peregrine Asset Advisers's portfolio in Q2 2026, its #14 holding.
- Peregrine Asset Advisers first reported a position in Eli Lilly in Q1 2020 and has held it in 16 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Peregrine Asset Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.